Thor Medical ASA (OSL:TRMED)
kr 1.018 0.014 (1.39%) Market Cap: 239.09 Mil Enterprise Value: 210.39 Mil PE Ratio: 0 PB Ratio: 0.93 GF Score: 39/100

Nordic Nanovector ASA - R&D Day Transcript

Nov 30, 2021 / 01:00PM GMT
Release Date Price: kr24.89 (-10.88%)
Jan Hendrik Egberts
Nordic Nanovector ASA - Independent Chairman of the Board

Good afternoon, ladies and gentlemen. Welcome to our Nordic Nanovector R&D Day. My name is Jan Egberts, and I'm the Chairperson of the company, Nordic Nanovector. Unfortunately, I was really looking forward to meet you all in person today in Oslo. But I guess, unfortunately, because of the -- all the corona-related travel restriction, that's not possible. However, we'll make the best out of it with using the more modern technology, it's the webcast and obviously, we will also be available for more intimately answering all your questions.

Obviously, corona had a major impact on our company. We have kept you updated about our recruitments, which suffered quite significantly in the first half of last year, which really starting to pick up now, which is very encouraging. Over the past months and years, we have been sharing a lot of information about our progress with PARADIGME, the clinical program with Betalutin.

I think it's now also very important to kind of switch gear a little bit and share what our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot